The Indian rupee has hit a record low near 90.48 against the US dollar, but the decline remains a calibrated move, says Naveen Mathur of Anand Rathi. In a detailed market outlook, he explains how Fed signals, FPI outflows, and delays in the India–US trade deal are pressuring the currency, and why the RBI may...Read More

India’s private credit market is increasingly dominated by real estate, absorbing 42% of deal volume in H1 FY25. This surge is fueled by structural demand, hard collateral, and financing gaps traditional lenders can’t fill. Developers are seeking bespoke capital solutions for various needs, making real estate the natural entry point for private credit.Read More

Indian markets are hitting new highs, but many investors are seeing losses in their portfolios. This disconnect is due to valuation corrections in mid and small-cap stocks. Experts believe the Indian economic story remains strong. Investors should watch for policy decisions and global stability. The focus is shifting towards quality growth companies.Read More

Four Nifty500 stocks, including Vodafone Idea, appeared in the White Marubozu bullish scan on December 11, signalling strong buying momentum. The candlestick pattern reflects firm control by buyers throughout the session, indicating potential continuation of upward trends as renewed interest and positive sentiment drive short-term trading opportunities.Read More

Insurance stocks may stay active as the Union Cabinet is expected to consider the Insurance Amendment Bill on Friday. The proposal reportedly includes major sector reforms, including raising FDI in insurers to 100% and other changes aimed at modernising the industry.Read More

The Indian rupee has fallen to a new record low against the US dollar. This decline is attributed to the lack of a trade deal with the United States and corporate dollar outflows. The Reserve Bank of India likely intervened to moderate the rupee’s slide.Read More

Interest surged across 9 stocks in the NSE F&O pack.Read More

Piramal Pharma’s US facility inspection concluded with four observations from the FDA. The company expects a voluntary action indicated classification. Piramal Pharma is preparing a response to the regulator. This comes as the company reported a net loss in the September quarter, impacted by its contract development and manufacturing segment. Shares have seen a decline...Read More

Methodhub Software is set to debut on the BSE SME platform on December 12. The company’s Initial Public Offering saw a robust subscription of 28.91 times. Despite this strong response, the grey market premium indicates moderate listing expectations. The IPO aims to raise funds for loan repayment, working capital, and expansion.Read More

ICICI Prudential AMC’s Rs 10,602 crore IPO opens for subscription on December 12. This is a pure offer for sale by its UK partner. The offer closes on December 16. The company manages significant assets and shows strong profitability. Brokerages recommend subscribing for long-term investment. Valuations are considered fair, with modest listing expectations.Read More